A 58-year-old man with a diagnosis of chronic Lyme disease

JAMA

Volumn 288, Issue 8, 2002, Pages 1002-1010

  Steere, Allen C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; HYDROXYCHLOROQUINE; PENICILLIN G SODIUM; TETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONICITY; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; DISEASE COURSE; DOSE RESPONSE; HUMAN; LABORATORY TEST; LYME DISEASE; MALE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0037190068     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.8.1002     Document Type: Article

References (79)

1. The spirochetal etiology of Lyme disease
2. Borrelia burgdorferi sp. nov.: Etiologic agent of Lyme disease
3. Surveillance for Lyme disease - United States, 1992-1998
4. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks
5. A longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population
6. Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts
7. Lyme disease
8. The early clinical manifestations of Lyme disease
9. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans
10. Neurologic abnormalities of Lyme disease
11. The triad of neurologic manifestations of Lyme disease: Meningitis, cranial neuritis, and radiculoneuritis
12. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein a with adjuvant
13. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease
14. Neurologic abnormalities of Lyme disease: Successful treatment with high-dose intravenous penicillin
15. The clinical evolution of Lyme arthritis
16. Evaluation of study patients with Lyme disease, 10-20-year follow-up
17. Chronic neurologic manifestations of Lyme disease
18. Lyme neuroborreliosis: Central nervous system manifestations
19. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis
20. Lyme disease: Cause of a treatable peripheral neuropathy
21. Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease
22. Lyme encephalopathy: A neuropsychological perspective
23. Reversible cerebral hypoperfusion in Lyme encephalopathy
24. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin
25. Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease
26. Lyme disease
27. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis
28. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in patients with Lyme neuroborreliosis
29. Intralaboratory reliability of serologic and urine testing for Lyme disease
30. Case definitions for public health surveillance
31. Recommendations for test performance and interpretation from the Second International Conference on serologic diagnosis of Lyme disease
32. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
33. Western blotting in the serodiagnosis of Lyme disease
34. Seronegative Lyme disease: Dissociation of the specific T- and B-lymphocyte responses to Borrelia burgdorferi
35. Seronegative Lyme disease
36. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease
37. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis
38. Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants
39. The surgical pathology of human Lyme disease: An enlarging picture
40. Practice guidelines for the treatment of Lyme disease
41. Lyme disease
42. Amoxicillin plus probenicid versus doxycycline for treatment of erythema migrans borreliosis
43. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease
44. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone
45. Summary of the first 100 patients seen at a Lyme disease referral center
46. Lyme disease associated with fibromyalgia
47. Memory impairment and depression in patients with Lyme encephalopathy: Comparison with fibromyalgia and nonpsychotically depressed patients
48. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease
49. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice
50. Clinical and neurocognitive features of the post-Lyme syndrome
51. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease
52. Long-term outcomes of persons with Lyme disease
53. Lyme disease in children in southeastern Connecticut
54. Psychiatric diagnoses in patients who have chronic fatigue syndrome
55. Psychiatric and psychologic aspects of fibromyalgia syndrome
56. Convalescence from influenza: A study of psychological and physical determinants
57. The overdiagnosis of Lyme disease
58. The consequences of overdiagnosis and overtreatment of Lyme disease
59. Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: First 65 patients
60. NIH conference: Chronic fatigue syndrome research: Definition and medical outcome assessment
61. Management of fibromyalgia
62. Biliary complications in the treatment of unsubstantiated Lyme disease
63. Death from inappropriate therapy for Lyme disease
64. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia
65. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: A randomized, doubleblind clinical trial
66. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
67. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome
68. Randomised, double-blind, placebocontrolled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome
69. A 56-year-old woman with chronic fatigue syndrome
70. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia
71. Prescribing exercise for fibromyalgia patients
72. Multidisciplinary group programs to treat fibromyalgia patients
73. Group treatment of fibromyalgia: A 6-month outpatient program
74. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomized controlled trial
75. Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial
76. A controlled study of stress-reduction, cognitive-behavioral treatment program in fibromyalgia
77. Cognitive behavioral treatment of fibromyalgia syndrome: A follow up assessment
78. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer-surface protein A (OspA) of Borrelia burgdorferi
79. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis